Related Experiment Video
Updated: Mar 29, 2026

X-Ray Crystallography to Study the Oligomeric State Transition of the Thermotoga maritima M42 Aminopeptidase TmPep1050
Published on: May 13, 2020
Structural basis for substrate specificity of Helicobacter pylori M17 aminopeptidase
Joyanta K Modak1, Wioletta Rut2, Lakshmi C Wijeyewickrema3
1Infection and Immunity Program, Monash Biomedical Discovery Institute and Department of Microbiology, Monash University, Clayton, Victoria, Australia.
Abstract:
The M17 aminopeptidase from the carcinogenic gastric bacterium Helicobacter pylori (HpM17AP) is an important housekeeping enzyme involved in catabolism of endogenous and exogenous peptides. It is implicated in H. pylori defence against the human innate immune response and in the mechanism of metronidazole resistance. Bestatin inhibits HpM17AP and suppresses H. pylori growth. To address the structural basis of catalysis and inhibition of this enzyme, we have established its specificity towards the N-terminal amino acid of peptide substrates and determined the crystal structures of HpM17AP and its complex with bestatin. The position of the D-phenylalanine moiety of the inhibitor with respect to the active-site metal ions, bicarbonate ion and with respect to other M17 aminopeptidases suggested that this residue binds to the S1 subsite of HpM17AP. In contrast to most characterized M17 aminopeptidases, HpM17AP displays preference for L-Arg over L-Leu residues in peptide substrates. Compared to very similar homologues from other bacteria, a distinguishing feature of HpM17AP is a hydrophilic pocket at the end of the S1 subsite that is likely to accommodate the charged head group of the L-Arg residue of the substrate. The pocket is flanked by a sodium ion (not present in M17 aminopeptidases that show preference for L-Leu) and its coordinating water molecules. In addition, the structure suggests that variable loops at the entrance to, and in the middle of, the substrate-binding channel are important determinants of substrate specificity of M17 aminopeptidases.
Insights
The Helicobacter pylori M17 aminopeptidase (HpM17AP) enzyme
Area of Science:
- Enzymology
- Structural Biology
- Microbiology
Background:
- Helicobacter pylori (H. pylori) is a gastric bacterium linked to cancer.
- HpM17AP is crucial for H. pylori survival and resistance.
- Bestatin is an inhibitor of HpM17AP, suppressing H. pylori growth.
Purpose of the Study:
- To elucidate the structural basis of HpM17AP catalysis and bestatin inhibition.
- To determine the substrate specificity of HpM17AP.
- To understand the structural features dictating HpM17AP's unique substrate preference.
Main Methods:
- Enzyme specificity assays.
- X-ray crystallography of HpM17AP and its complex with bestatin.
Main Results:
- HpM17AP exhibits a preference for L-Arg over L-Leu residues.
- A unique hydrophilic pocket in the S1 subsite accommodates L-Arg.
- This pocket is flanked by a sodium ion, distinguishing it from other M17 aminopeptidases.
- Variable loops influence substrate-binding channel specificity.
Conclusions:
- Structural insights into HpM17AP's active site explain its L-Arg preference.
- The identified structural features provide a basis for designing targeted inhibitors.
- Understanding HpM17AP's structure and function aids in developing strategies against H. pylori infections.
More Related Videos
09:47The Determination of Protease Specificity in Mouse Tissue Extracts by MALDI-TOF Mass Spectrometry: Manipulating PH to Cause Specificity Changes
Published on: May 25, 2018
10:44One-step Negative Chromatographic Purification of Helicobacter pylori Neutrophil-activating Protein Overexpressed in Escherichia coli in Batch Mode
Published on: June 18, 2016
Related Concept Videos
Peptic Ulcer
Allosteric Proteins-ATCase
Aspartate transcarbamoylase (ATCase) is a cytosolic enzyme that catalyzes the condensation of L-aspartate and carbamoyl phosphate to N-carbamoyl-L-aspartate. This reaction is the first step in pyrimidine biosynthesis. UTP and CTP, the end products of the pyrimidine synthesis...
Ligand Binding and Linkage
Basicity of Heterocyclic Aromatic Amines
Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy
Pathophysiology of Peptic Ulcer Disease: Mucosal Defense Factors